Marco Tagliamento

Researcher/Assistant Professor

University of Genoa

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marco Tagliamento is an Assistant Professor at the University of Genoa, Italy. His research primarily focuses on immunotherapy and targeted therapies in lung cancer, with recent publications exploring neoadjuvant approaches, the role of immune checkpoint inhibitors, and the genomic landscape of cancer mutations. He also investigates the implications of body mass index in chemotherapy efficacy and the use of circulating tumor DNA in treatment guidance.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (6)

Antonin LEVY, MD, PhD

Université Paris-Saclay

FRANCE

View details

Mariana Brandão

Institut Jules Bordet

BELGIUM

View details

LAURA MEZQUITA

University of Barcelona

SPAIN

View details

Javier Gavira Díaz

Institut Català d'Oncologia

SPAIN

View details

Idris Bahce

Amsterdam University Medical Centers

NETHERLANDS

View details

Juan Aguilar-Company

Vall d´Hebron Institut d´Oncologia

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marco Tagliamento

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer

Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses

Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives

Time to rethink platinum choices in the era of immunotherapy in lung cancer

Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes

Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer

Brief Report: Targeted Therapies and Pancreatitis in Patients With Advanced Nonsmall Cell Lung Cancer

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease

Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients

Collaborators (6)

Antonin LEVY, MD, PhD

Mariana Brandão

LAURA MEZQUITA

Javier Gavira Díaz

Idris Bahce

Juan Aguilar-Company

Make your next move.